1 terminated, 1 withdrawn. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Terminated 1, Withdrawn 1 |
| Phase 2 | 1 | Terminated 1 |
Follow Lymphatic Malformation: new trials by email Literature Review of Lymphatic Malformation trials Research Report on Lymphatic Malformation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Pharmacokinetic, Pharmacodynamic, Safety and Tolerability Study of CERC-006 in Adults With Complex Lymphatic Malformations CERC-006 - Lymphatic Malformation | Phase 1 | Withdrawn | Avalo Therapeutics, Inc. | 2021-09-03 | 2022-03-22 | |
| First in Human Trial of Topical VT30 in Pts With Venous/Lymphatic Malformations Assoc With PIK3CA or TEK Gene Mutations VT30 - Venous Malformation, Lymphatic Malformation | Phase 1 / Phase 2 | Terminated | Venthera, Inc., a BridgeBio company | 15 | 2020-10-01 | 2022-08-04 |
Congenital Abnormalities (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Hemic and Lymphatic Diseases (2) · Lymphatic Diseases (2)
Avalo Therapeutics, Inc. (1) · Venthera, Inc., a BridgeBio company (1)
United States (2)